tsn

Investigator Points to Study Showing Placebo and Antibiotics Essentially Same Result Against Lower Respiratory Tract Infection or Mild Pneumonia

 156
1 comment
Staff at TrialSite | Quality Journalism
Jul. 13, 2024, 5:00 p.m.

An internal medicine and infectious diseases specialist Professor Evangelos J. Giamarellos-Bourboulis brings significant research contributions in immunomodulation in sepsis and in auto-inflammatory disorders. Awarded the Young Investigator Research Award by the European Society of Clinical Microbiology and Infectious Diseases, Giamarellos-Bourboulis has received a total of 39 awards for his studies on sepsis and has published 433 peer-reviewed articles in international scientific journals. Most recently, this notable physician-scientist contributed works to the prestigious The Lancet Respiratory MedicineNoting that respiratory tract infections represent the largest cause behind unnecessary consumption of antibiotics, this latter action leads to exploding antimicrobial resistance across communities worldwide.

What about patients with comorbidities or those patients with frequent episodes of infection? Dr.  Giamarellos-Bourboulis suggests an even bigger influence.

Quality journalism costs money to produce.

Free access provides up to 10 articles

Subscription options start at $5 per month 
which is less than a Starbucks coffee!

Peter Gabriel, MD
"Publishing on TrialSite helped me secure a $20m research grant for my work."
Jona Savinda
"TrialSiteNews is my daily read for what is happening in the industry."
Lucas Van Der Hoven
"Objective, unbiased reporting on the latest news in medical research. I trust TrialSiteNews to give it to me straight."
TrialSiteNews
159 W Broadway, Suite 200
Salt Lake City, UT 84101
© 2025 - Trial Site News